FDA clears MDS Nordion's Monte Carlo software:
This article was originally published in Clinica
Executive Summary
MDS Nordion has received US FDA 510(k) clearance to market its Monte Carlo radiotherapy dose calculation software for cancer patients. The Monte Carlo electron dose calculation algorithms will be used in MDS' new Oncentra treatment planning software and will run on the desktop, producing accurate dose calculations in minutes rather than hours, claims the Ottawa, Canada firm. The software was also recently approved in Canada.